ARMISTICE CAPITAL, LLC
Top Portfolio Positions
228 positions ·
$4,736,277,466 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio |
|---|---|---|---|---|
| SPY |
Spdr S&P 500 ETF Trust
|
2,100,000 | $1,365,714,000 | 28.84% |
| AGIO |
Agios Pharmaceuticals, Inc.
Healthcare
|
5,916,000 | $200,138,280 | 4.23% |
| CYTK |
Cytokinetics Inc
Healthcare
|
2,664,538 | $175,619,699 | 3.71% |
| PTCT |
Ptc Therapeutics, Inc.
Healthcare
|
2,464,449 | $167,902,910 | 3.55% |
| TVTX |
Travere Therapeutics, Inc.
Healthcare
|
4,897,417 | $145,502,259 | 3.07% |
| MDGL |
Madrigal Pharmaceuticals, Inc.
Healthcare
|
264,583 | $138,501,263 | 2.92% |
| IMVT |
Immunovant, Inc.
Healthcare
|
5,464,916 | $135,748,513 | 2.87% |
| SUPN |
Supernus Pharmaceuticals, Inc.
Healthcare
|
1,895,347 | $97,970,486 | 2.07% |
| NBIX |
Neurocrine Biosciences Inc
Healthcare
|
724,000 | $95,379,760 | 2.01% |
| FRPT |
Freshpet, Inc.
Consumer Defensive
|
1,093,307 | $64,461,380 | 1.36% |
Portfolio Trend
Holdings in ARGX
Shares Held
Position Value (USD)
24 of 24 shown
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2025-12-31 | $48,775,100 | 58,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $42,778,480 | 58,000 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $44,097,600 | 80,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $58,002,770 | 98,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $76,260,000 | 124,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $82,396,160 | 152,000 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $86,008,000 | 200,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $103,942,080 | 264,000 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $120,976,740 | 318,000 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $68,828,200 | 140,000 | Call | Sole | 2023-11-14 | |
| 2023-09-30 | $98,326,000 | 200,000 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $77,946,000 | 200,000 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $83,457,920 | 224,000 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $64,401,100 | 170,000 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $42,366,000 | 120,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $71,229,440 | 188,000 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $63,062,000 | 200,000 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $65,835,720 | 188,000 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $62,816,000 | 208,000 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $53,590,460 | 178,000 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $41,308,500 | 150,000 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $23,527,200 | 80,000 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $22,314,200 | 85,000 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $15,315,640 | 68,000 | Shares | Defined | 2020-08-14 | |
| No quarters match your search. | ||||||